---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-191783"
form_type: "8-K"
ticker: "FBRX"
cik: "0001419041"
company_name: "Forte Biosciences, Inc."
filed_at: "2022-07-12T23:59:59+00:00"
generated_at: "2026-06-24T16:35:27.114596+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Forte Biosciences adopts poison pill rights plan with 10% trigger

## Summary
- Board declares dividend of one Right per share of common stock; record date July 21, 2022.
- Rights exercisable at $16 per one thousandth of Series A Participating Preferred share.
- Rights become exercisable if a person acquires 10% (20% for certain institutional holders) of common stock.
- Rights expire on July 12, 2023, redeemable at $0.001 per Right at board's option.
- Certificate of Designation for Series A Preferred filed with Delaware Secretary of State.

## SEC filing metadata
- accession: 0001193125-22-191783
- form_type: 8-K
- ticker: FBRX
- cik: 0001419041
- company_name: Forte Biosciences, Inc.
- filed_at: 2022-07-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419041/000119312522191783/0001193125-22-191783-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419041/000119312522191783/d598392d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-191783
- JSON: https://secwatch.observer/filing/0001193125-22-191783.json
- Plain text: https://secwatch.observer/filing/0001193125-22-191783.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.